![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 28, 26605-26613, July 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Previous studies showed that following acute
carbon tetrachloride (CCl4) treatment, interleukin-6
null (IL-6
Interleukin-6 Protects against
Fas-mediated Death by Establishing a Critical Level of
Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL*
§¶,
¶,
,
, and
**
Department of Genetics, the
§ Department of Medicine, Division of Gastroenterology,
University of Pennsylvania Medical School, Philadelphia, Pennsylvania
19104 and the
Istituto Ricerce di Biologia Molecolare (IRBM),
00040 Rome, Italy
/
) mice develop increased hepatocellular injury,
defective regeneration, delayed wound healing, and increased hepatocyte
apoptosis. Pretreatment with IL-6 prior to CCl4 reduces
injury, hepatocyte apoptosis, and accelerates regeneration in both
IL-6
/
and +/+ livers. To demonstrate whether IL-6 can prevent liver
injury that involves direct stimulation of hepatocyte apoptosis,
IL-6
/
and +/+ mice were treated with the Fas agonist, Jo-2 mAb. At
low Fas agonist doses, IL-6+/+ mice developed mild hepatic injury and
survived, whereas IL-6
/
mice developed severe apoptotic hepatitis
within 12 h and died. Pretreatment with IL-6 improved survival in
IL-6
/
mice and reduced injury in both IL-6
/
and +/+ livers. The
direct anti-apoptotic effects of IL-6 were demonstrated in
vitro as IL-6 decreased Fas-mediated apoptosis in both IL-6
/
and +/+ primary hepatocyte cultures, and suggested that IL-6
/
hepatocytes have a pre-existing defect in anti-apoptotic pathways.
After Fas activation, IL-6
/
livers demonstrated evidence of both
proximal and distal alterations in the apoptotic pathways including
elevated caspase 8 and 3 activation-associated fragments, and loss of
cytochrome c staining. IL-6
/
livers had reduced
pre-existing protein expression of the anti-apoptotic factors Bcl-2 and
Bcl-xL as well as more rapid degradation of FLIP following Fas
treatment that appeared to be post-transcriptionally regulated. FLIP is
a crucial proximal inhibitor of caspase 8 activation in Fas, tumor
necrosis factor, and DR3/DR4-mediated apoptosis, and Bcl-2 and
Bcl-xL more downstream anti-apoptotic regulators. IL-6 may function as
a critical anti-apoptotic factor in the liver by its ability to
establish and maintain an adequate level of FLIP and downstream
anti-apoptotic factors.
*
This work was supported by University of Pennsylvania
Digestive and Liver Center Grant P30 DK50306 and in part by National Institutes of Health Grants 1 F32 DK09732-01 and 1 K08 DK
02667-01 (to K. K.) and DK 49629 (to R. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
F Caprioli, C Stolfi, R Caruso, D Fina, G Sica, L Biancone, F Pallone, and G Monteleone Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation Gut, December 1, 2008; 57(12): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ellingsgaard, J. A. Ehses, E. B. Hammar, L. Van Lommel, R. Quintens, G. Martens, J. Kerr-Conte, F. Pattou, T. Berney, D. Pipeleers, et al. Interleukin-6 regulates pancreatic {alpha}-cell mass expansion PNAS, September 2, 2008; 105(35): 13163 - 13168. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Chong, C. S. Boehlke, Q.-D. Zheng, L. Zhang, Y. Han, and D. N. Zacks Interleukin-6 as a Photoreceptor Neuroprotectant in an Experimental Model of Retinal Detachment Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3193 - 3200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hu and L. M. Colletti Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G45 - G53. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nechemia-Arbely, D. Barkan, G. Pizov, A. Shriki, S. Rose-John, E. Galun, and J. H. Axelrod IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1106 - 1115. [Full Text] [PDF] |
||||
![]() |
C. Porta, M. De Amici, S. Quaglini, C. Paglino, F. Tagliani, A. Boncimino, R. Moratti, and G. R. Corazza Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma Ann. Onc., February 1, 2008; 19(2): 353 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Riehle, J. S. Campbell, R. S. McMahan, M. M. Johnson, R. P. Beyer, T. K. Bammler, and N. Fausto Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3 J. Exp. Med., January 21, 2008; 205(1): 91 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dvorak, M. Chavarria, C. M. Payne, L. Ramsey, C. Crowley-Weber, B. Dvorakova, B. Dvorak, H. Bernstein, H. Holubec, R. E. Sampliner, et al. Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus Clin. Cancer Res., September 15, 2007; 13(18): 5305 - 5313. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamada, A. Sato, T. Hirano, T. Yamamoto, G. Son, M. Onodera, I. Torii, T. Nishigami, M. Tanaka, A. Miyajima, et al. Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats Am. J. Pathol., September 1, 2007; 171(3): 872 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pevsner-Fischer, V. Morad, M. Cohen-Sfady, L. Rousso-Noori, A. Zanin-Zhorov, S. Cohen, I. R. Cohen, and D. Zipori Toll-like receptors and their ligands control mesenchymal stem cell functions Blood, February 15, 2007; 109(4): 1422 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsuzaki, Y. Xu, M. Ikegami, V. Besnard, K.-S. Park, W. M. Hull, S. E. Wert, and J. A. Whitsett Stat3 Is Required for Cytoprotection of the Respiratory Epithelium during Adenoviral Infection J. Immunol., July 1, 2006; 177(1): 527 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jones Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6 J. Immunol., September 15, 2005; 175(6): 3463 - 3468. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Manna, J. Dimitry, P.-A. Oldenborg, and W. A. Frazier CD47 Augments Fas/CD95-mediated Apoptosis J. Biol. Chem., August 19, 2005; 280(33): 29637 - 29644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Chida, N Sudo, A Takaki, and C Kubo The hepatic sympathetic nerve plays a critical role in preventing Fas induced liver injury in mice Gut, July 1, 2005; 54(7): 994 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berasain, E. R. Garcia-Trevijano, J. Castillo, E. Erroba, M. Santamaria, D. C. Lee, J. Prieto, and M. A. Avila Novel Role for Amphiregulin in Protection from Liver Injury J. Biol. Chem., May 13, 2005; 280(19): 19012 - 19020. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rochman, W. E. Paul, and S. Z. Ben-Sasson IL-6 Increases Primed Cell Expansion and Survival J. Immunol., April 15, 2005; 174(8): 4761 - 4767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Sanz, J B Pucilowska, S Liu, C M Rodriguez-Ortigosa, P K Lund, D A Brenner, C R Fuller, J G Simmons, A Pardo, M-L Martinez-Chantar, et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury Gut, January 1, 2005; 54(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Cousens, F. A. Goulette, and J. W. Darnowski JAK-Mediated Signaling Inhibits Fas Ligand-Induced Apoptosis Independent of De Novo Protein Synthesis J. Immunol., January 1, 2005; 174(1): 320 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Argast, J. S. Campbell, J. T. Brooling, and N. Fausto Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication J. Biol. Chem., August 13, 2004; 279(33): 34530 - 34536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sun, Z. Tian, S. Kulkarni, and B. Gao IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent Manners J. Immunol., May 1, 2004; 172(9): 5648 - 5655. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jiang and D. S. Pisetsky The Effect of Dexamethasone on the Generation of Plasma DNA from Dead and Dying Cells Am. J. Pathol., May 1, 2004; 164(5): 1751 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. James, S. S. McCullough, L. W. Lamps, and J. A. Hinson Effect of N-Acetylcysteine on Acetaminophen Toxicity in Mice: Relationship to Reactive Nitrogen and Cytokine Formation Toxicol. Sci., October 1, 2003; 75(2): 458 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Kristiansen, R. L. Nolsoe, L. Larsen, A. M.P. Gjesing, J. Johannesen, Z. M. Larsen, A. E. Lykkesfeldt, A. E. Karlsen, F. Pociot, T. Mandrup-Poulsen, et al. Association of a functional 17{beta}-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females Hum. Mol. Genet., May 15, 2003; 12(10): 1101 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiao, S. I. Han, Y. Fang, J. S. Park, S. Gupta, D. Gilfor, G. Amorino, K. Valerie, L. Sealy, J. F. Engelhardt, et al. Bile Acid Regulation of C/EBP{beta}, CREB, and c-Jun Function, via the Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Pathways, Modulates the Apoptotic Response of Hepatocytes Mol. Cell. Biol., May 1, 2003; 23(9): 3052 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wuestefeld, C. Klein, K. L. Streetz, U. Betz, J. Lauber, J. Buer, M. P. Manns, W. Muller, and C. Trautwein Interleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration J. Biol. Chem., March 21, 2003; 278(13): 11281 - 11288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Leu, M. A. S. Crissey, L. E. Craig, and R. Taub Impaired Hepatocyte DNA Synthetic Response Posthepatectomy in Insulin-Like Growth Factor Binding Protein 1-Deficient Mice with Defects in C/EBP{beta} and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Regulation Mol. Cell. Biol., February 15, 2003; 23(4): 1251 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seki, Y. Hayakawa, A. D. Brooks, J. Wine, R. H. Wiltrout, H. Yagita, J. E. Tanner, M. J. Smyth, and T. J. Sayers Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis Is an Important Endogenous Mechanism for Resistance to Liver Metastases in Murine Renal Cancer Cancer Res., January 1, 2003; 63(1): 207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-Gossmann, A. Atfi, F. Morel, H. Ichijo, and C. Guguen-Guillouzo Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation J. Biol. Chem., December 13, 2002; 277(51): 49220 - 49229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tarn, L. Zou, R. L. Hullinger, and O. M. Andrisani Hepatitis B Virus X Protein Activates the p38 Mitogen-Activated Protein Kinase Pathway in Dedifferentiated Hepatocytes J. Virol., August 28, 2002; 76(19): 9763 - 9772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Macias-Silva, W. Li, J. I. Leu, M. A. S. Crissey, and R. Taub Up-regulated Transcriptional Repressors SnoN and Ski Bind Smad Proteins to Antagonize Transforming Growth Factor-beta Signals during Liver Regeneration J. Biol. Chem., August 2, 2002; 277(32): 28483 - 28490. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. E. Deiry, et al. Deoxycholic Acid (DCA) Causes Ligand-independent Activation of Epidermal Growth Factor Receptor (EGFR) and FAS Receptor in Primary Hepatocytes: Inhibition of EGFR/Mitogen-activated Protein Kinase-Signaling Module Enhances DCA-induced Apoptosis Mol. Biol. Cell, September 1, 2001; 12(9): 2629 - 2645. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |